Cargando…
Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers
Tumor-associated inflammation leads to dysregulated cytokine production that promotes tumor immune evasion and anti-tumor immunity dysfunction. In advanced stage breast cancer, the proinflammatory cytokine IL-1β is overexpressed due to large proportions of activated myeloid cells in the tumor microe...
Autores principales: | Tengesdal, Isak W., Li, Suzhao, Powers, Nicholas E., May, Makenna, Neff, Charles P., Joosten, Leo A. B., Marchetti, Carlo, Dinarello, Charles A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144656/ https://www.ncbi.nlm.nih.gov/pubmed/35631400 http://dx.doi.org/10.3390/ph15050574 |
Ejemplares similares
-
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
por: Marchetti, Carlo, et al.
Publicado: (2018) -
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression
por: Tengesdal, Isak W., et al.
Publicado: (2021) -
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
por: Marchetti, Carlo, et al.
Publicado: (2018) -
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions
por: Dinarello, Alberto, et al.
Publicado: (2023) -
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
por: Tengesdal, Isak W., et al.
Publicado: (2021)